Resistance to tumor graft in mice treated with inactivated Brucella abortus cultured in smooth or rough phase
- PMID: 102858
Resistance to tumor graft in mice treated with inactivated Brucella abortus cultured in smooth or rough phase
Abstract
Because killed Brucella abortus organisms cultured in smooth (S) or rough (R) phase were known to differentially influence humoral and cellular immune responses and to differ in their effects on T-dependent responses, the antitumor properties of killed B. abortus organisms, cultured in S- or R-phase and then inactivated, were compared in (C57BL/6 X DBA/2)F1 female mice with the use of 6 different transplantable tumors. In solid tumors, the antitumor effects produced by S-preparations were never improved by R-preparations. However, in ascites tumors, R-preparations gave the best antitumor results. These findings suggested that the defense mechanisms acrivated by immunostimulants may differ according to the site of tumor implantation. Among the other experimental factors studied, the route of B. abortus administration had a prominent role. Local injection at the site of tumor implantation before or after the graft gave better results than did systemic treatment. Systemic treatment could enhance the growth of Lewis tumor when applied 5 or 10 days before tumor graft but generally had an antitumor effect when given 1 day after the graft.
Similar articles
-
Increased resistance to tumor graft in mice infected by vaccinal strains of Brucella abortus.Recent Results Cancer Res. 1980;75:92-9. doi: 10.1007/978-3-642-81491-4_15. Recent Results Cancer Res. 1980. PMID: 6785847
-
Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.J Clin Invest. 1998 Jan 15;101(2):429-41. doi: 10.1172/JCI1348. J Clin Invest. 1998. PMID: 9435316 Free PMC article.
-
Macrophage involvement in the antitumor activity of Brucella abortus ether extract against experimental lung carcinoma metastases.Cancer Res. 1978 Oct;38(10):3427-31. Cancer Res. 1978. PMID: 99230 No abstract available.
-
Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.Vaccine. 2006 Apr 5;24(15):2910-6. doi: 10.1016/j.vaccine.2005.12.038. Epub 2006 Jan 6. Vaccine. 2006. PMID: 16439039
-
Antitumor activity of cell walls from Brucella abortus.J Natl Cancer Inst. 1983 Sep;71(3):529-34. J Natl Cancer Inst. 1983. PMID: 6411957
Cited by
-
Scintigraphic detection in mice of inflammatory lesions and tumours by an indium-labelled monoclonal antibody directed against Mac-1 antigen.Cancer Immunol Immunother. 1988;26(3):237-42. doi: 10.1007/BF00199935. Cancer Immunol Immunother. 1988. PMID: 3289745 Free PMC article.
-
Influence of the culture conditions of Brucella abortus on its antitumor properties.Cancer Immunol Immunother. 1983;14(3):207-8. doi: 10.1007/BF00205363. Cancer Immunol Immunother. 1983. PMID: 6404552 Free PMC article.
-
An anti-mouse macrophage monoclonal antibody reacting with T-derived leukaemic cells.Immunology. 1984 Jul;52(3):539-46. Immunology. 1984. PMID: 6204931 Free PMC article.